91΄σΟγ½Ά

91΄σΟγ½Ά
91΄σΟγ½Ά 91΄σΟγ½Ά
GettyImages-145652391-hero
headshot

T. Clark Gamblin, MD, MS, MBA

Professor, Surgical Oncology; Vice Chair Clinical Operations

view physician profile

Locations

  • Froedtert Hospital
  • Froedtert Menomonee Falls Hospital
  • Froedtert West Bend Hospital
  • Zablocki VA Medical Center
  • Cancer Center - Froedtert Hospital

Specialties

  • Surgical Oncology
  • General Surgery

Languages

  • English

Established Patient Appointments

New Patient Appointments

Education

  • MD - Doctor of Medicine
  • MS -Master of Science
  • MBA - Master of Business Administration

Biography

T. Clark Gamblin, MD, MS, MBA, The Stuart D. Wilson Chair in Surgical Oncology is the Chief of Surgical Oncology and the Vice Chair for Off-Campus Clinical Operations for the 91΄σΟγ½Ά. Dr. Gamblin joined The 91΄σΟγ½Ά in 2010 from the University of Pittsburgh School of Medicine. Dr. Gamblin’s practice is focused on hepatobiliary cancer and other gastrointestinal malignancies.

Dr. Gamblin serves on the editorial board for the Annals of Surgery, Annals of Surgical Oncology, and the Journal of Surgical Oncology. He holds memberships in numerous professional and scientific societies including the American Surgical Association and the Society of Clinical Surgery. Dr. Gamblin has more than 225 peer reviewed publications and has authored multiple reviews and book chapters in addition to editing 3 books. He has presented more than 100 lectures on the multimodality management of liver tumors to regional, national and international audiences.

Research Experience

  • Carcinoma, Hepatocellular
  • Liver
  • Liver Diseases
  • Liver Neoplasms

Clinical Expertise

  • Advanced abdominal malignancies
  • Bile Ducts
  • Carcinoma, Hepatocellular
  • Digestive System Diseases
  • Gallbladder
  • General Surgery
  • Hepatectomy
  • Infusion Pumps, Implantable
  • Liver Neoplasms

Methodologies and Techniques

  • Comparative Study
  • Multicenter Studies as Topic
  • Outcome Assessment (Health Care)
  • Practice Guideline
  • Therapies, Investigational
  • Xenograft Model Antitumor Assays

Leadership Positions

  • Co-Director of HPB Surgery Clinical Fellowship
  • Vice Chair, Clinical Operations

Research Interests

Dr. Gamblin’s research interests include utilizing large dataset to optimize management and outcomes of hepatobiliary patients. He has led multiple research efforts including clinical trials on the treatment of hepatocellular carcinoma and cholangiocarcinoma.

Publications

  • (Gamboa AC, Kooby DA, Maithel SK, Gamblin TC.) J Surg Oncol. 2024 Jan;129(1):63-70 PMID: 38059310 SCOPUS ID: 2-s2.0-85178962332 12/07/2023

  • (Lundberg RK, Elftmann AE, Wilson SD, Gamblin TC.) Am Surg. 2023 Dec;89(12):6449-6451 PMID: 37655602 SCOPUS ID: 2-s2.0-85170555678 09/01/2023

  • (Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan M.) HPB (Oxford). 2023 Aug;25(8):933-940 PMID: 37149486 SCOPUS ID: 2-s2.0-85158153721 05/07/2023

  • (Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN.) J Surg Res. 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023

  • (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN.) Sci Rep. 2023 Jul 08;13(1):11051 PMID: 37422500 PMCID: PMC10329647 SCOPUS ID: 2-s2.0-85164146540 07/09/2023

  • (Thalji SZ, Ethun CG, Tsai S, Gamblin TC, Clarke CN, Bedi M, King D, LoGiudice J, Poultsides G, Grignol VP, Tseng J, Votanopoulos K, Fields RC, Cardona K, Mogal H.) J Surg Oncol. 2023 Mar;127(4):550-559 PMID: 36477427 SCOPUS ID: 2-s2.0-85147711222 12/09/2022

  • (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN.) Scientific Reports. December 2023;13(1) SCOPUS ID: 2-s2.0-85164146540 12/01/2023

  • (Servin-Rojas M, Shafique N, Sell NM, Gamblin TC, Qadan M.) HPB. August 2023;25(8):933-940 SCOPUS ID: 2-s2.0-85158153721 08/01/2023

  • (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN.) J Surg Res. 2022 Oct;278:31-38 PMID: 35588572 SCOPUS ID: 2-s2.0-85130316020 05/20/2022

  • (Chrabaszcz S, Rajeev R, Witmer HDD, Dhiman A, Klooster B, Gamblin TC, Banerjee A, Johnston FM, Turaga KK.) Am J Clin Oncol. 2022 Aug 01;45(8):366-372 PMID: 35838247 SCOPUS ID: 2-s2.0-85135132818 07/16/2022

  • (Franssen S, Soares KC, Jolissaint JS, Tsilimigras DI, Buettner S, Alexandrescu S, Marques H, Lamelas J, Aldrighetti L, Gamblin TC, Maithel SK, Pulitano C, Margonis GA, Weiss MJ, Bauer TW, Shen F, Poultsides GA, Marsh JW, Cercek A, Kemeny N, Kingham TP, D'Angelica M, Pawlik TM, Jarnagin WR, Koerkamp BG.) JAMA Surg. 2022 Jul 01;157(7):590-596 PMID: 35544131 PMCID: PMC9096688 SCOPUS ID: 2-s2.0-85130546813 05/12/2022

  • (Baker T, Tabrizian P, Zendejas I, Gamblin TC, Kazimi M, Boudjema K, Geller D, Salem R.) HPB (Oxford). 2022 Jul;24(7):1007-1018 PMID: 35012876 SCOPUS ID: 2-s2.0-85122536501 01/12/2022

Publications of from the